Validation for histology-driven diagnosis in non-small cell lung cancer using hsa-miR-205 and hsa-miR-21 expression by two different normalization strategies

Targeted therapy of non-small cell lung cancer (NSCLC) demands a more accurate tumor classification that is crucial for patient selection in personalized treatment. MicroRNAs constitute a promising class of biomarkers and a helpful tool for the distinction between lung adenocarcinoma (AC) and squamo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Charkiewicz, Radosław (VerfasserIn) , Pilz, Lothar R. (VerfasserIn) , Manegold, Christian (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2016
In: International journal of cancer
Year: 2016, Jahrgang: 138, Heft: 3, Pages: 689-697
ISSN:1097-0215
DOI:10.1002/ijc.29816
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1002/ijc.29816
Verlag, Volltext: https://onlinelibrary-wiley-com.ezproxy.medma.uni-heidelberg.de/doi/abs/10.1002/ijc.29816
Volltext
Verfasserangaben:Radoslaw Charkiewicz, Lothar Pilz, Anetta Sulewska, Miroslaw Kozlowski, Wieslawa Niklinska, Marcin Moniuszko, Joanna Reszec, Christian Manegold and Jacek Niklinski

MARC

LEADER 00000caa a2200000 c 4500
001 1586575864
003 DE-627
005 20220815093729.0
007 cr uuu---uuuuu
008 190125s2016 xx |||||o 00| ||eng c
024 7 |a 10.1002/ijc.29816  |2 doi 
035 |a (DE-627)1586575864 
035 |a (DE-576)516575864 
035 |a (DE-599)BSZ516575864 
035 |a (OCoLC)1341034313 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Charkiewicz, Radosław  |e VerfasserIn  |0 (DE-588)1176207032  |0 (DE-627)1047365375  |0 (DE-576)516575619  |4 aut 
245 1 0 |a Validation for histology-driven diagnosis in non-small cell lung cancer using hsa-miR-205 and hsa-miR-21 expression by two different normalization strategies  |c Radoslaw Charkiewicz, Lothar Pilz, Anetta Sulewska, Miroslaw Kozlowski, Wieslawa Niklinska, Marcin Moniuszko, Joanna Reszec, Christian Manegold and Jacek Niklinski 
264 1 |c 2016 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 25.01.2019 
500 |a Online 27 Aug 2015 
520 |a Targeted therapy of non-small cell lung cancer (NSCLC) demands a more accurate tumor classification that is crucial for patient selection in personalized treatment. MicroRNAs constitute a promising class of biomarkers and a helpful tool for the distinction between lung adenocarcinoma (AC) and squamous cell lung carcinoma (SCC). The aim of this study was to evaluate the impact of two different normalization strategies, using U6 snRNA and hsa-miR-103 as reference genes, on hsa-miR-205 and hsa-miR-21 expression levels, in terms of the classification of subtypes of NSCLC. By means of a quantitative real-time polymerase chain reaction (qRT-PCR) microRNA expression levels were evaluated in a classification set of 98 surgically resected NSCLC fresh-frozen samples, and validated findings in an independent set of 42 NSCLC samples. The microRNA expression levels were exploited to develop a diagnostic test using two data normalization strategies. The performance of microRNA profiling in different normalization methods was compared. We revealed the microRNA-based qRT-PCR tests to be appropriate measures for distinguishing between AC and SCC (the concordance of histologic diagnoses and molecular methods greater than 88%). Performance evaluation of microRNA tests, based on the two normalization strategies, showed that the procedure using hsa-miR-103 as reference target has a slight advantage (sensitivity 83.33 and 100% in classification and validation set, respectively) compared to U6 snRNA. Molecular tests based on microRNA expression allow a reliable classification of subtypes for NSCLC and can constitute a useful diagnostic strategy in patient selection for targeted therapy. 
650 4 |a microRNA 
650 4 |a non-small cell lung cancer 
650 4 |a subclassification 
650 4 |a target therapy 
700 1 |a Pilz, Lothar R.  |d 1954-  |e VerfasserIn  |0 (DE-588)1036758621  |0 (DE-627)751686107  |0 (DE-576)38680799X  |4 aut 
700 1 |a Manegold, Christian  |d 1946-2022  |e VerfasserIn  |0 (DE-588)108614913  |0 (DE-627)490287360  |0 (DE-576)289617200  |4 aut 
773 0 8 |i Enthalten in  |t International journal of cancer  |d Bognor Regis : Wiley-Liss, 1966  |g 138(2016), 3, Seite 689-697  |h Online-Ressource  |w (DE-627)269532781  |w (DE-600)1474822-8  |w (DE-576)079876129  |x 1097-0215  |7 nnas  |a Validation for histology-driven diagnosis in non-small cell lung cancer using hsa-miR-205 and hsa-miR-21 expression by two different normalization strategies 
773 1 8 |g volume:138  |g year:2016  |g number:3  |g pages:689-697  |g extent:9  |a Validation for histology-driven diagnosis in non-small cell lung cancer using hsa-miR-205 and hsa-miR-21 expression by two different normalization strategies 
856 4 0 |u http://dx.doi.org/10.1002/ijc.29816  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://onlinelibrary-wiley-com.ezproxy.medma.uni-heidelberg.de/doi/abs/10.1002/ijc.29816  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20190125 
993 |a Article 
994 |a 2016 
998 |g 108614913  |a Manegold, Christian  |m 108614913:Manegold, Christian  |d 60000  |e 60000PM108614913  |k 0/60000/  |p 8 
998 |g 1036758621  |a Pilz, Lothar R.  |m 1036758621:Pilz, Lothar R.  |d 60000  |e 60000PP1036758621  |k 0/60000/  |p 2 
999 |a KXP-PPN1586575864  |e 3048913025 
BIB |a Y 
SER |a journal 
JSO |a {"physDesc":[{"extent":"9 S."}],"relHost":[{"origin":[{"dateIssuedDisp":"1966-","publisher":"Wiley-Liss","dateIssuedKey":"1966","publisherPlace":"Bognor Regis"}],"id":{"issn":["1097-0215"],"doi":["10.1002/(ISSN)1097-0215"],"eki":["269532781"],"zdb":["1474822-8"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"International journal of cancer","title":"International journal of cancer","subtitle":"publication of the International Union against Cancer (UICC) = Journal international du cancer"}],"pubHistory":["1.1966 -"],"titleTranslated":[{"translated":"Journal international du cancer"}],"titleAlt":[{"title":"Predictive oncology"}],"part":{"year":"2016","issue":"3","pages":"689-697","text":"138(2016), 3, Seite 689-697","volume":"138","extent":"9"},"note":["Gesehen am 28.02.08","Darin: Predictive oncology"],"disp":"Validation for histology-driven diagnosis in non-small cell lung cancer using hsa-miR-205 and hsa-miR-21 expression by two different normalization strategiesInternational journal of cancer","type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"269532781","corporate":[{"role":"isb","roleDisplay":"Herausgebendes Organ","display":"International Union against Cancer"}],"language":["eng"]}],"name":{"displayForm":["Radoslaw Charkiewicz, Lothar Pilz, Anetta Sulewska, Miroslaw Kozlowski, Wieslawa Niklinska, Marcin Moniuszko, Joanna Reszec, Christian Manegold and Jacek Niklinski"]},"origin":[{"dateIssuedKey":"2016","dateIssuedDisp":"2016"}],"id":{"eki":["1586575864"],"doi":["10.1002/ijc.29816"]},"note":["Gesehen am 25.01.2019","Online 27 Aug 2015"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"recId":"1586575864","language":["eng"],"person":[{"given":"Radosław","family":"Charkiewicz","role":"aut","display":"Charkiewicz, Radosław","roleDisplay":"VerfasserIn"},{"role":"aut","display":"Pilz, Lothar R.","roleDisplay":"VerfasserIn","given":"Lothar R.","family":"Pilz"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Manegold, Christian","given":"Christian","family":"Manegold"}],"title":[{"title":"Validation for histology-driven diagnosis in non-small cell lung cancer using hsa-miR-205 and hsa-miR-21 expression by two different normalization strategies","title_sort":"Validation for histology-driven diagnosis in non-small cell lung cancer using hsa-miR-205 and hsa-miR-21 expression by two different normalization strategies"}]} 
SRT |a CHARKIEWICVALIDATION2016